Tumor Ablation Market By Function (Automated/Robotic Ablation, Conventional Ablation Devices), By Technology (Hyperthermic Ablation, Radiofrequency Ablation, Microwave Ablation, Laser Ablation, Ultrasound Ablation, Cryoablation), By Application (Primary Lung Cancer, Metastatic Diseases, Pain Palliation), By End User (Hospitals, Oncology Institutes, Diagnostic Centers) and Geography 

Tumor Ablation Market size was estimated at USD 620.71 million in 2023 and is poised to grow at a CAGR of 13.2% from 2024-2030. Tumor ablation is a minimally invasive surgical method that enables treats solid tumors in which special probes are used to freeze or burn cancers without the usual surgery. The tumor ablation method is guided by the help of a CT scan, MRI Scan and ultrasound to locate and position the needle probe into the tumor which requires a tiny hole of 3mm diameter to introduce the probe. When the probe is within the cancer it is attached to a generator that burns and freezes the cancer. The most common cancers that are treated by this method are lung cancer, renal cancer, and liver cancer. Innovations in resources and technologies required in tumor ablation have provided ample opportunities for various pharma and electronics companies to work for the betterment of currently available technologies. Innovations such as high-intensity focused ultrasound (HIFU), irreversible electroporation and image-guided procedures are rising demand for adaptation of tumor ablation.  

Tumor Ablation Market Key Developments:

• In 2016, Medtronic launched Barrx360 express radiofrequency ablation balloon catheter to treat Barrett's oesophagus
• In 2016 May, BTG Plc. has acquired Galil Medical, cryoablation systems, and needles manufacturer.
• In 2015 January, Medtronic acquired Covidien which has improved its product portfolio of tumor ablation products.